GLP - 1 Analogs: Newer Molecules, Newer Uses

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|3|2|129-134

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.3, Iss.2, 2009-06, pp. : 129-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linagliptin and Newer DPP-4 Inhibitors: Newer Uses and Newer Indications

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 197-202

Bentham Science Publishers

Access to resources Recommend Favorite

Liraglutide-A Novel GLP-1 Analogue

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 200-204

Bentham Science Publishers

Access to resources Recommend Favorite

GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 3, 2007-11 ,pp. : 193-201

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel Use of GLP-1 Analogue and Insulin Combination in Type 2 Diabetes Mellitus

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite

Incretins Yesterday, Pleiotropic Gastrointestinal Hormones Today:Glucagon-Like Peptide-1 (GLP-1) and Glucose-ependent Insulinotropic Polypeptide (GIP)

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 176-182

Bentham Science Publishers

Access to resources Recommend Favorite